Some most common adverse reactions include allergic reactions, blood clots in the brain, blood clotting problems and high blood sugar.
Other severe side effects of Pegaspargase include serious thrombosis, glucose intolerance, and coagulopathy.
Pegaspargase Indicated for the treatment of:
Some most common adverse reactions include allergic reactions, blood clots in the brain, blood clotting problems and high blood sugar.
Other severe side effects of Pegaspargase include serious thrombosis, glucose intolerance, and coagulopathy.
Some most common adverse reactions include allergic reactions, blood clots in the brain, blood clotting problems and high blood sugar.
Other severe side effects of Pegaspargase include serious thrombosis, glucose intolerance, and coagulopathy.
Care should be exercised in the handling of Oncaspar (Pegaspargase). Pegaspargase Store under refrigeration at 2°C to 8ºC (36°F to 46°F). Do not shake or freeze product. Protect from light.
No formal drug interaction studies, between Pegaspargase and other drugs, have been performed.
Acute Lymphoblastic Leukemia is one of the most common childhood cancer, which spread when bone marrow cells develop an error in its DNA.
Pegaspargase is an anti-cancer chemotherapy drug; it is a tetrameric enzyme.
It works based on the selective killing of leukemic cells due to the depletion of plasma asparagine. Some leukemic cells cannot synthesize asparagine due to a lack of asparagine synthetase and are dependent on an exogenous source of asparagine for survival. Pegaspargase is L-asparaginase (L’Asparagine amidohydrolase) that kills the leukemic cells.
Pegaspargase is the active ingredient, and the inactive ingredients are monobasic sodium phosphate, dibasic sodium phosphate, sodium chloride, and water.
The most common adverse effects include bone pain, frequent infections, bleeding gums, fever, and enlarged lymph nodes.
The prognosis for childhood leukemia has increased and children with Acute Lymphoblastic Leukemia are estimated to have a 95% probability rate in order to overcome with ALL, after the treatment of the initial 4 weeks.
Patients can simply fill the order form or can send mail at info@ikrispharmanetwork.com. Patient can also send WhatsApp message to +91 8130290915. We will reply ASAP with the details of Pricing and procedure.
Note:- The order will be confirmed only after the receipt of Valid prescription of Clinician
All Trademark and Brand that appear on the website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. Pegaspargase Injection 3750 IU/5 ml is a pharmaceutical drug that legally requires a medical prescription to be dispensed.
Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller and Pharmacies.